Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology (original) (raw)

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Maia Parsadanian

Proceedings of the National Academy of Sciences, 2000

View PDFchevron_right

Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade

Huntington Potter

International journal of Alzheimer's disease, 2012

View PDFchevron_right

Apolipoprotein E and Alzheimer's disease: The protective effects of ApoE2 and E3

M. Kindy

Journal of Alzheimer's Disease, 2002

View PDFchevron_right

Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease

Yansheng Du

Proceedings of the National Academy of Sciences, 1999

View PDFchevron_right

Apolipoprotein E in Alzheimer's disease and other neurological disorders

Philip Verghese

The Lancet Neurology, 2011

View PDFchevron_right

Apolipoprotein E, Amyloid, and Alzheimer Disease

JC Dodart

Molecular Interventions, 2002

View PDFchevron_right

Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid- Amyloidosis

Jungsu Kim

Journal of Neuroscience, 2011

View PDFchevron_right

Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease

Elizabeth Corder

Cellular and Molecular Life Sciences (CMLS), 1999

View PDFchevron_right

Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease

Maia Parsadanian

Journal of Clinical Investigation, 1999

View PDFchevron_right

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Zachary Trottier

Molecular Neurodegeneration

View PDFchevron_right

The Role of Apolipoprotein E in Alzheimer's Disease

Jungsu Kim

Neuron, 2009

View PDFchevron_right

Apolipoprotein E metabolism and functions in brain and its role in Alzheimerʼs disease

Fan Liao

Current Opinion in Lipidology, 2016

View PDFchevron_right

Human APOE Isoform-Dependent Effects on Brain -Amyloid Levels in PDAPP Transgenic Mice

SUIZHEN LIN

Journal of Neuroscience, 2009

View PDFchevron_right

Opposite Roles of Apolipoprotein E in Normal Brains and in Alzheimer's Disease

claudio russo

Proceedings of The National Academy of Sciences, 1998

View PDFchevron_right

Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease

Judes Poirier

Alzheimer's & Dementia, 2008

View PDFchevron_right

Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses

Ann Saunders

Journal of neuropathology and experimental neurology, 2000

View PDFchevron_right

Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice

Michael Vitek

Journal of Neuroscience, 2008

View PDFchevron_right

Association of human, rat, and rabbit apolipoprotein E with β‐amyloid

Godfrey Getz

Journal of Neuroscience Research, 1997

View PDFchevron_right

Current knowledge on the relationship between ApoE and Alzheimer’s disease

Myrthe aan de Stegge

2018

View PDFchevron_right

Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/−Mice: Isoform-Specific Effects on Neurodegeneration

Robert Mahley

The Journal of Neuroscience, 1999

View PDFchevron_right

Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease

JC Dodart

Proceedings of the National Academy of Sciences, 2005

View PDFchevron_right

Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models

Fan Liao

Acta neuropathologica communications, 2015

View PDFchevron_right

Apolipoprotein (apo) E4 enhances amyloid peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target

Elaine Meng, Irwin Kuntz

Proceedings of the National Academy of Sciences, 2005

View PDFchevron_right

Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

Madia LOZUPONE

Therapeutic Advances in Chronic Disease, 2022

View PDFchevron_right

Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease

Jungsu Kim

Alzheimer's Research & Therapy, 2013

View PDFchevron_right

Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls

Nenad Bogdanovic, Terho Lehtimäki

Brain Research, 1996

View PDFchevron_right

Apolipoprotein E Genotype Regulates Amyloid- Cytotoxicity

Irene Otte-höller

Journal of Neuroscience, 2005

View PDFchevron_right